A single measurement of fecal hemoglobin concentration outperforms polygenic risk score in colorectal cancer risk assessment

Cancer Commun (Lond). 2023 Aug;43(8):947-950. doi: 10.1002/cac2.12448. Epub 2023 Jun 4.

Authors

Tobias Niedermaier¹, Elizabeth Alwers¹, Xuechen Chen^{1

2}, Thomas Heisser^{1

2}, Michael Hoffmeister¹, Hermann Brenner^{1

3

4}

Affiliations

¹ Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Baden-Württemberg, Germany.
² Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Baden-Württemberg, Germany.
³ Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg, Baden-Württemberg, Germany.
⁴ German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Baden-Württemberg, Germany.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Colonoscopy*
Colorectal Neoplasms* / diagnosis
Colorectal Neoplasms* / genetics
Hemoglobins / analysis
Hemoglobins / genetics
Humans
Risk Assessment
Risk Factors

Substances

Hemoglobins